ANALYSIS OF DIRECT MEDICAL COSTS FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS AGED 2 TO 60 MONTHS AT GREEN INTERNATIONAL HOSPITAL IN 2024

Quang Tuấn Hà 1,, Thị Hương Trà Hà 1, Văn Thắng Đỗ 1, Thị Huyền Trang Lê 1
1 Haiphong University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To analyze the direct medical costs associated with the treatment of community-acquired pneumonia (CAP) in pediatric patients aged 2 to 60 months at Green International Hospital in 2024. Subjects and Methods: A retrospective, cross-sectional study was conducted using data from "Treatment Cost Statements" of pediatric inpatients aged 2 to 60 months diagnosed with community-acquired pneumonia and hospitalized at Green International Hospital from January 1, 2024, to June 30, 2024. Results: Out-of-pocket payments accounted for the majority of total treatment costs (86,25%), while health insurance contributions covered only 13,75%. The average direct medical cost per hospitalization was VND 12,495 million VNĐ. Treatment-related costs comprised the largest portion (87,31%) of total direct costs, including bed-day costs (44,68%, highest proportion), surgical/procedural costs (21,94%), drug and infusion costs (16,73%), and medical supplies (3,97%). Diagnostic costs accounted for 12,45%, primarily from laboratory tests (8,63%). Among medications used, antibiotics represented the highest proportion (58,85%). Conclusion: The majority of the treatment costs for community-acquired pneumonia at Green International Hospital were borne by patients, with bed-day charges constituting the largest share, followed by costs for surgical/procedural interventions and medications.

Article Details

References

1. UNICEF, A child dies of pneumonia every 43 seconds. 2023.
2. Bộ Y tế, Hướng dẫn sử dụng kháng sinh. 2015.
3. Bùi Thị Xuân; Phạm, V. Đ; Hoàng, V. H. (2019). Phân tích chi phí điều trị viêm phổi ở trẻ em tại bệnh viện Bạch Mai Hà Nội từ tháng 10/2018 đến tháng 3/2019. VNU Journal of Science: Medical and Pharmaceutical Sciences, Vol. 35, No. 2 (2019) 96-104.
4. Trương Đình Phong, et al., Phân tích chi phí và các yếu tố ảnh hưởng đến chi phí trực tiếp điều trị bệnh viêm phổi tại bệnh viện trẻ em Hải Phòng năm 2020. Tạp chí y học việt nam, 2023. 529(1).
5. Tan, K.K., et al., Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea. Hum Vaccin Immunother, 2018. 14(1): p. 95-105.
6. Li, Y., et al., Disease burden of community acquired pneumonia among children under 5 year old in China: A population based survey. 2017. 13(7): p. 1681-1687.
7. Nguyễn Trọng Duy Thức, et al., phân tích chi phí trực tiếp y tế trong điều trị nội trú bệnh viêm phổi do vi khuẩn cho trẻ em có bảo hiểm y tế tại bệnh viện Nhi Lâm Đồng giai đoạn 2019-2020. Tạp chí y học việt nam, 2021. 505.
8. Bộ Y tế, Hướng dẫn sử dụng kháng sinh. 2015.